Market Research Logo

Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2017

Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, “Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2017 provides an overview of Transdermal Drug Delivery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transdermal Drug Delivery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.Scope

  • Extensive coverage of the Transdermal Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transdermal Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transdermal Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Transdermal Drug Delivery Devices Overview
  • Products under Development
    • Transdermal Drug Delivery Devices - Pipeline Products by Stage of under Development
      • Table Figure 1: Transdermal Drug Delivery Devices - Pipeline Products by Stage of under Development
      • Table Transdermal Drug Delivery Devices - Pipeline Products by Stage of under Development
    • Transdermal Drug Delivery Devices - Pipeline Products by Segment
      • Table Figure 2: Transdermal Drug Delivery Devices - Pipeline Products by Segment Pipeline Products by Segment n=154
      • Table Transdermal Drug Delivery Devices - Pipeline Products by Segment
    • Transdermal Drug Delivery Devices - Pipeline Products by Territory
      • Table Figure 3: Transdermal Drug Delivery Devices - Pipeline Products by Territory
      • Table Transdermal Drug Delivery Devices - Pipeline Products by Territory
    • Transdermal Drug Delivery Devices - Pipeline Products by Regulatory Path
      • Table Figure 4: Transdermal Drug Delivery Devices - Pipeline Products by Regulatory Path
      • Table Transdermal Drug Delivery Devices - Pipeline Products by Regulatory Path
    • Transdermal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
      • Table Figure 5: Transdermal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
      • Table Transdermal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
    • Transdermal Drug Delivery Devices - Ongoing Clinical Trials
      • Table Figure 6: Transdermal Drug Delivery Devices - Ongoing Clinical Trials
      • Table Transdermal Drug Delivery Devices - Ongoing Clinical Trials
  • Transdermal Drug Delivery Devices - Pipeline Products under Development by Companies
    • Transdermal Drug Delivery Devices Companies - Pipeline Products by Stage of Development
      • Table Transdermal Drug Delivery Devices Companies - Pipeline Products by Stage of Development
    • Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
      • Table Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
  • Transdermal Drug Delivery Devices Companies and Product Overview
    • 3M Co Company Overview
      • 3M Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3M Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3M Hollow Microstructured Transdermal System - Product Status
        • Table 3M Hollow Microstructured Transdermal System - Product Description
    • 4P Therapeutics LLC Company Overview
      • 4P Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table 4P Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transdermal FSH Patch - Product Status
        • Table Transdermal FSH Patch - Product Description
    • Actuated Medical Inc Company Overview
      • Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GentleDispense System - Product Status
        • Table GentleDispense System - Product Description
    • Aequus Pharmaceuticals Inc Company Overview
      • Aequus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aequus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AQS1301 - Product Status
        • Table AQS1301 - Product Description
        • Table AQS1302 - Product Status
        • Table AQS1302 - Product Description
        • Table AQS1303 - Product Status
        • Table AQS1303 - Product Description
        • Table AQS1304 - Product Status
        • Table AQS1304 - Product Description
        • Table Aequus Pharmaceuticals Inc - Ongoing Clinical Trials Overview
        • Table AQS1301 - Phase Ia Study of AQS-1301 in Healthy Subjects
    • Agile Therapeutics Inc Company Overview
      • Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AG200-ER Patch - Product Status
        • Table AG200-ER Patch - Product Description
        • Table AG200-SP Patch - Product Status
        • Table AG200-SP Patch - Product Description
        • Table AG890 Patch - Product Status
        • Table AG890 Patch - Product Description
        • Table Twirla (AG200-15) - Product Status
        • Table Twirla (AG200-15) - Product Description
    • Allergan Plc Company Overview
      • Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanotechnology-Based Transdermal Delivery System - Product Status
        • Table Nanotechnology-Based Transdermal Delivery System - Product Description
        • Table Norethindrone Transdermal Delivery System - Product Status
        • Table Norethindrone Transdermal Delivery System - Product Description
    • Alliqua BioMedical Inc Company Overview
      • Alliqua BioMedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alliqua BioMedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PHN Patch - Product Status
        • Table PHN Patch - Product Description
    • Altea Therapeutics Corporation (Inactive) Company Overview
      • Altea Therapeutics Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Altea Therapeutics Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table PassPort Exenatide Transdermal Delivery System - Product Status
        • Table PassPort Exenatide Transdermal Delivery System - Product Description
        • Table Transdermal Enoxaparin Sodium Patch - Product Status
        • Table Transdermal Enoxaparin Sodium Patch - Product Description
        • Table Transdermal Fentanyl Citrate Patch - Product Status
        • Table Transdermal Fentanyl Citrate Patch - Product Description
        • Table Transdermal Protein Patch - Product Status
        • Table Transdermal Protein Patch - Product Description
    • AMW GmbH Company Overview
      • AMW GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table AMW GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rotigotine Patch - Product Status
        • Table Rotigotine Patch - Product Description
        • Table Transdermal Patch - Breast Cancer - Product Status
        • Table Transdermal Patch - Breast Cancer - Product Description
    • Apogee Technology Inc Company Overview
      • Apogee Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Apogee Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PyraDerm - Product Status
        • Table PyraDerm - Product Description
    • Apricus Biosciences Inc Company Overview
      • Apricus Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Apricus Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vitaros - Product Status
        • Table Vitaros - Product Description
    • Aquavit Pharmaceuticals Inc Company Overview
      • Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table iMicrotox - Product Status
        • Table iMicrotox - Product Description
        • Table Aquavit Pharmaceuticals Inc - Ongoing Clinical Trials Overview
        • Table iMicrotox - Efficacy of iMicrotox to Treat Mild-to-moderate Peri-orbital Rhytids
    • AstraZeneca Plc Company Overview
      • AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EMLA Patch - Product Status
        • Table EMLA Patch - Product Description
    • Avro Life Sciences Company Overview
      • Avro Life Sciences Pipeline Products & Ongoing Clinical Trials Overview
        • Table Avro Life Sciences Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transdermal Drug Delivery Patch - Product Status
        • Table Transdermal Drug Delivery Patch - Product Description
    • Axxia Pharmaceuticals, LLC Company Overview
      • Axxia Pharmaceuticals, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Axxia Pharmaceuticals, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug Delivery Implant - Product Status
        • Table Drug Delivery Implant - Product Description
    • Burke Pharmaceuticals LLC Company Overview
      • Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table BLU402 Hydrogel Patch Wart Kit - Product Status
        • Table BLU402 Hydrogel Patch Wart Kit - Product Description
        • Table Drug Delivery Patch - Product Status
        • Table Drug Delivery Patch - Product Description
    • CB Scientific Inc. Company Overview
      • CB Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table CB Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pain-Patch - Product Status
        • Table Pain-Patch - Product Description
    • Cerimon Pharmaceuticals, Inc. (Inactive) Company Overview
      • Cerimon Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cerimon Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Topical Diclofenac Patch - Product Status
        • Table Topical Diclofenac Patch - Product Description
    • Chrono Therapeutics Inc Company Overview
      • Chrono Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Chrono Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biologically-Timed Drug Delivery Device - Product Status
        • Table Biologically-Timed Drug Delivery Device - Product Description
    • Corium International Inc Company Overview
      • Corium International Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Corium International Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Corplex Donepezil Transdermal System - Product Status
        • Table Corplex Donepezil Transdermal System - Product Description
        • Table Corplex Memantine Transdermal System - Product Status
        • Table Corplex Memantine Transdermal System - Product Description
        • Table Corplex Ropinirole Transdermal System - Product Status
        • Table Corplex Ropinirole Transdermal System - Product Description
        • Table MicroCor Transdermal System - Product Status
        • Table MicroCor Transdermal System - Product Description
        • Table MicroCor Zolmitriptan System - Product Status
        • Table MicroCor Zolmitriptan System - Product Description
        • Table MicroJet - Product Status
        • Table MicroJet - Product Description
        • Table Corium International Inc - Ongoing Clinical Trials Overview
        • Table Corplex Donepezil Transdermal System - A Phase I Crossover Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of Two Formulations of a 7-day Application Donepezil Transdermal Delivery System (TDS) Compared to Oral Administration of Aricept in Healthy Volunteers
        • Table Corplex Donepezil Transdermal System - A Study to Assess the Steady-state Bioequivalence of Once-weekly Corplex Donepezil Transdermal Delivery System Compared to Daily Oral Administration of Aricept
        • Table Corplex Donepezil Transdermal System - Phase 1 Clinical Trial of Corplex Donepezil Transdermal System for the Treatment of Alzheimer's Disease
    • DBV Technologies SA Company Overview
      • DBV Technologies SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table DBV Technologies SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Viaskin Peanut - Product Status
        • Table Viaskin Peanut - Product Description
        • Table DBV Technologies SA - Ongoing Clinical Trials Overview
        • Table Viaskin Peanut - A Double-blind, Placebo-controlled, Randomized Phase 3 Pivotal Trial to Assess the Efficacy and Safety of Peanut Epicutaneous Immunotherapy with Viaskin Peanut in Peanut-allergic Children
        • Table Viaskin Peanut - A Double-blind, Placebo-controlled, Randomized Phase III Trial to Assess the Safety and Efficacy of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age
        • Table Viaskin Peanut - Open-label Follow-up Study of the PEPITES Study to Evaluate the Long-term Efficacy and Safety of Viaskin Peanut
        • Table Viaskin Peanut - Safety Study of Viaskin Peanut to Treat Peanut Allergy (REALISE)
    • Dermisonics, Inc. Company Overview
      • Dermisonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dermisonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table U-Strip - Product Status
        • Table U-Strip - Product Description
    • Dharma Therapeutics, Inc. (Inactive) Company Overview
      • Dharma Therapeutics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dharma Therapeutics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Iontophoretic Drug Delivery Patch - Product Status
        • Table Iontophoretic Drug Delivery Patch - Product Description
    • DURECT Corp Company Overview
      • DURECT Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table DURECT Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eladur - Product Status
        • Table Eladur - Product Description
    • Echo Therapeutics Inc Company Overview
      • Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prelude SkinPrep System - Product Status
        • Table Prelude SkinPrep System - Product Description
    • Emplicure AB Company Overview
      • Emplicure AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Emplicure AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Micro-needle Patch - Product Status
        • Table Micro-needle Patch - Product Description
        • Table Tamper Resistant Patch - Product Status
        • Table Tamper Resistant Patch - Product Description
    • Endo International Plc Company Overview
      • Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rivastigmine Patch - Product Status
        • Table Rivastigmine Patch - Product Description
    • Extend Biosciences Inc Company Overview
      • Extend Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Extend Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Non-Invasive Needle-Free Skin Patch - Product Status
        • Table Non-Invasive Needle-Free Skin Patch - Product Description
    • EyeGate Pharmaceuticals Inc Company Overview
      • EyeGate Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EyeGate Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EyeGate II Delivery System - Product Status
        • Table EyeGate II Delivery System - Product Description
        • Table EyeGate Pharmaceuticals Inc - Ongoing Clinical Trials Overview
        • Table EyeGate II Delivery System - A Prospective, Multi-center, Randomized, Double-masked, Positive Controlled, Phase III Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution Compared to Prednisolone Acetate Ophthalmic Suspension
        • Table EyeGate II Delivery System - Multi-center, Double-masked, Randomized, Placebo-controlled Phase IIb Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients Having Undergone Cataract Surgery with Implantation of a Posterior Chamber Intraocular Lens (IOL)
    • Fe3 Medical Inc Company Overview
      • Fe3 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fe3 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Iron Supplement Patch - Product Status
        • Table Iron Supplement Patch - Product Description
    • FluGen Inc Company Overview
      • FluGen Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table FluGen Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table FLUGEN 101.2 Microneedle-based Delivery Device - Product Status
        • Table FLUGEN 101.2 Microneedle-based Delivery Device - Product Description
    • French National Institute of Health and Medical Research Company Overview
      • French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table Polyelectrolyte Multilayer Film System - Product Status
        • Table Polyelectrolyte Multilayer Film System - Product Description
    • Hisamitsu Pharmaceutical Co Inc Company Overview
      • Hisamitsu Pharmaceutical Co Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hisamitsu Pharmaceutical Co Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ATS Adhesive Skin Patch - Product Status
        • Table ATS Adhesive Skin Patch - Product Description
        • Table Fentos Tape - Product Status
        • Table Fentos Tape - Product Description
        • Table HP - 3000 Idiopathic Restless Legs Syndrome - Product Status
        • Table HP - 3000 Idiopathic Restless Legs Syndrome - Product Description
        • Table HP-1010 Adhesive Skin Patch - Product Status
        • Table HP-1010 Adhesive Skin Patch - Product Description
        • Table HP-1030 Adhesive Skin Patch - Product Status
        • Table HP-1030 Adhesive Skin Patch - Product Description
        • Table HP-3000 Adhesive Skin Patch - Product Status
        • Table HP-3000 Adhesive Skin Patch - Product Description
        • Table HP-3060 Adhesive Skin Patch - Product Status
        • Table HP-3060 Adhesive Skin Patch - Product Description
        • Table HP-3070 Adhesive Skin Patch - Product Status
        • Table HP-3070 Adhesive Skin Patch - Product Description
        • Table HP-3150 Adhesive Skin Patch - Product Status
        • Table HP-3150 Adhesive Skin Patch - Product Description
        • Table HTU-520 Patch - Product Status
        • Table HTU-520 Patch - Product Description
        • Table Hisamitsu Pharmaceutical Co Inc - Ongoing Clinical Trials Overview
        • Table HP-3070 Adhesive Skin Patch - A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, 6- Week, In-Patient Study to Assess Efficacy and Safety of HP-3070 in Subjects Diagnosed with Schizophrenia
    • ImmuPatch Company Overview
      • ImmuPatch Pipeline Products & Ongoing Clinical Trials Overview
        • Table ImmuPatch Pipeline Products & Ongoing Clinical Trials Overview
        • Table Coated ImmuPatch - Product Status
        • Table Coated ImmuPatch - Product Description
        • Table Dissolvable ImmuPatch - Product Status
        • Table Dissolvable ImmuPatch - Product Description
    • Imperial College London Company Overview
      • Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Skin Patch - Prostate Cancer - Product Status
        • Table Skin Patch - Prostate Cancer - Product Description
    • Indian Institute of Science Company Overview
      • Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview
        • Table Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview
        • Table Indian Institute of Science Drug Delivery Patch - Product Status
        • Table Indian Institute of Science Drug Delivery Patch - Product Description
    • Indian Institute of Technology Bombay Company Overview
      • Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview
        • Table Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview
        • Table Poly (n-Vinyl Caprolactam) Based Patch - Product Status
        • Table Poly (n-Vinyl Caprolactam) Based Patch - Product Description
    • InMed Pharmaceuticals Inc Company Overview
      • InMed Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table InMed Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table INM-750 - Drug Delivery Device - Product Status
        • Table INM-750 - Drug Delivery Device - Product Description
    • Institute of Materials Research & Engineering Company Overview
      • Institute of Materials Research & Engineering Pipeline Products & Ongoing Clinical Trials Overview
        • Table Institute of Materials Research & Engineering Pipeline Products & Ongoing Clinical Trials Overview
        • Table Skin Breaching Device - Product Status
        • Table Skin Breaching Device - Product Description
    • Intercell AG (Inactive) Company Overview
      • Intercell AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Intercell AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Travelers Diarrhea Vaccine Patch - Product Status
        • Table Travelers Diarrhea Vaccine Patch - Product Description
    • Interstitial NS Company Overview
      • Interstitial NS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Interstitial NS Pipeline Products & Ongoing Clinical Trials Overview
        • Table NanoMAP - Product Status
        • Table NanoMAP - Product Description
    • Isis Biopolymer, Inc. Company Overview
      • Isis Biopolymer, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Isis Biopolymer, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gentle Touch - Product Status
        • Table Gentle Touch - Product Description
        • Table IsisIQ CLI - Product Status
        • Table IsisIQ CLI - Product Description
        • Table Isis Biopolymer, Inc. - Ongoing Clinical Trials Overview
        • Table Gentle Touch - Laser Hair Reduction by Combined Bipolar RF and 755 nm Laser Energies
    • Janisys Company Overview
      • Janisys Pipeline Products & Ongoing Clinical Trials Overview
        • Table Janisys Pipeline Products & Ongoing Clinical Trials Overview
        • Table Janisys Drug Delivery System - Product Status
        • Table Janisys Drug Delivery System - Product Description
    • Kalvista Pharmaceuticals Inc Company Overview
      • Kalvista Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Kalvista Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AdvaCoat Rx - Product Status
        • Table AdvaCoat Rx - Product Description
    • KTH Royal Institute of Technology Company Overview
      • KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microneedles Based Skin Patch - Product Status
        • Table Microneedles Based Skin Patch - Product Description
    • Kyowa Hakko Kirin Co Ltd Company Overview
      • Kyowa Hakko Kirin Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Kyowa Hakko Kirin Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sancuso Patch - Product Status
        • Table Sancuso Patch - Product Description
    • Massachusetts Institute of Technology Company Overview
      • Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Jet-Injection System - New Version - Product Status
        • Table Jet-Injection System - New Version - Product Description
    • Mayne Pharma International Pty Ltd Company Overview
      • Mayne Pharma International Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mayne Pharma International Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Motion Sickness Transdermal Delivery System Patch - Product Status
        • Table Motion Sickness Transdermal Delivery System Patch - Product Description
    • Medherant Ltd Company Overview
      • Medherant Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medherant Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ibuprofen TEPI Patch - Product Status
        • Table Ibuprofen TEPI Patch - Product Description
    • MEDRx Co Ltd Company Overview
      • MEDRx Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table MEDRx Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Etoreat - Product Status
        • Table Etoreat - Product Description
        • Table MRX-1OXT Patch - Product Status
        • Table MRX-1OXT Patch - Product Description
        • Table MRX-4TZT - Product Status
        • Table MRX-4TZT - Product Description
        • Table MRX-5DML - Product Status
        • Table MRX-5DML - Product Description
        • Table MRX-5LBT Patch - Product Status
        • Table MRX-5LBT Patch - Product Description
        • Table MRX-7LAT Lidocaine Patch - Product Status
        • Table MRX-7LAT Lidocaine Patch - Product Description
    • mesoestetic USA Inc Company Overview
      • mesoestetic USA Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table mesoestetic USA Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TMT System - Product Status
        • Table TMT System - Product Description
    • Microdermics Inc Company Overview
      • Microdermics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microdermics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microneedle Drug Delivery System - Product Status
        • Table Microneedle Drug Delivery System - Product Description
    • Micropoint Technologies Pte Ltd Company Overview
      • Micropoint Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Micropoint Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug-coated Micropoint Patch - Product Status
        • Table Drug-coated Micropoint Patch - Product Description
    • National Taiwan Ocean University Company Overview
      • National Taiwan Ocean University Pipeline Products & Ongoing Clinical Trials Overview
        • Table National Taiwan Ocean University Pipeline Products & Ongoing Clinical Trials Overview
        • Table DNA Vaccine Patch - Product Status
        • Table DNA Vaccine Patch - Product Description
    • Nemaura Pharma Ltd Company Overview
      • Nemaura Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nemaura Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Micropatch - Product Status
        • Table Micropatch - Product Description
        • Table Transdermal Patch - Product Status
        • Table Transdermal Patch - Product Description
    • NeuroDerm Ltd Company Overview
      • NeuroDerm Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table NeuroDerm Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table ND0601 Dermal Patch - Product Status
        • Table ND0601 Dermal Patch - Product Description
        • Table ND0611 Dermal Patch - Product Status
        • Table ND0611 Dermal Patch - Product Description
        • Table ND0901 - Product Status
        • Table ND0901 - Product Description
    • Nitto Denko Corp Company Overview
      • Nitto Denko Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nitto Denko Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table PassPort Transdermal Basal Insulin Patch - 12 Hours - Product Status
        • Table PassPort Transdermal Basal Insulin Patch - 12 Hours - Product Description
        • Table PassPort Transdermal Basal Insulin Patch - 24Hours - Product Status
        • Table PassPort Transdermal Basal Insulin Patch - 24Hours - Product Description
    • North Carolina State University Company Overview
      • North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Antibody Delivery Microneedle Patch - Product Status
        • Table Antibody Delivery Microneedle Patch - Product Description
        • Table Intraconazole Microneedles - Product Status
        • Table Intraconazole Microneedles - Product Description
    • Novosanis NV Company Overview
      • Novosanis NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Novosanis NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table VAX-ID - Product Status
        • Table VAX-ID - Product Description
        • Table Novosanis NV - Ongoing Clinical Trials Overview
        • Table VAX-ID - Echographic Imaging Research to the Anatomical and Physiological Characteristics of the Skin in Children and Adolescents
    • Nuvo Pharmaceuticals Inc Company Overview
      • Nuvo Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nuvo Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alprazolam Patch - Product Status
        • Table Alprazolam Patch - Product Description
    • Old Dominion University Company Overview
      • Old Dominion University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Old Dominion University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thermal Gene Electro Transfer Device - Product Status
        • Table Thermal Gene Electro Transfer Device - Product Description
    • Pain Therapeutics Inc Company Overview
      • Pain Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pain Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table FENROCK - Product Status
        • Table FENROCK - Product Description
    • Pantec Biosolutions AG Company Overview
      • Pantec Biosolutions AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pantec Biosolutions AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table P.L.E.A.S.E. Private - Product Status
        • Table P.L.E.A.S.E. Private - Product Description
    • Phosphagenics Ltd Company Overview
      • Phosphagenics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Phosphagenics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Localized Drug Delivery System - Lidocaine - Product Status
        • Table Localized Drug Delivery System - Lidocaine - Product Description
        • Table Localized Drug Delivery System-Diclofenac - Product Status
        • Table Localized Drug Delivery System-Diclofenac - Product Description
        • Table TPM-Oxycodone Patch - Product Status
        • Table TPM-Oxycodone Patch - Product Description
        • Table TPM-Oxymorphone Patch - Product Status
        • Table TPM-Oxymorphone Patch - Product Description
        • Table Phosphagenics Ltd - Ongoing Clinical Trials Overview
        • Table TPM-Oxycodone Patch - Oxycodone Patch Dosing in Phase 2 Clinical Trial
    • Purdue University Company Overview
      • Purdue University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Purdue University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pump For Drug-Delivery Patch - Product Status
        • Table Pump For Drug-Delivery Patch - Product Description
    • Radius Health Inc Company Overview
      • Radius Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Radius Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Abaloparatide TD - Osteoporosis - Product Status
        • Table Abaloparatide TD - Osteoporosis - Product Description
    • Ratio Inc Company Overview
      • Ratio Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ratio Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NuPrivo - Product Status
        • Table NuPrivo - Product Description
    • Scilex Ltd Company Overview
      • Scilex Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Scilex Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table D2T Patch - Acute Pain - Product Status
        • Table D2T Patch - Acute Pain - Product Description
        • Table ZTlido - Product Status
        • Table ZTlido - Product Description
    • Sensile Medical AG Company Overview
      • Sensile Medical AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sensile Medical AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table SensePatch 20 ml - Product Status
        • Table SensePatch 20 ml - Product Description
    • Skinject Inc Company Overview
      • Skinject Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Skinject Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SkinJect PatchIT - Product Status
        • Table SkinJect PatchIT - Product Description
    • Sparsha Pharma International Pvt Ltd Company Overview
      • Sparsha Pharma International Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sparsha Pharma International Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table 5-HT3 Receptor Antagonist Patch - Product Status
        • Table 5-HT3 Receptor Antagonist Patch - Product Description
        • Table Tulobuterol Patch - Product Status
        • Table Tulobuterol Patch - Product Description
    • Sparsha Pharma USA Inc Company Overview
      • Sparsha Pharma USA Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sparsha Pharma USA Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fen-Touch - Product Status
        • Table Fen-Touch - Product Description
    • Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
      • Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Micro Needle Patch - Product Status
        • Table Micro Needle Patch - Product Description
    • Stanford University Company Overview
      • Stanford University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stanford University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dissolving Microneedles - Product Status
        • Table Dissolving Microneedles - Product Description
    • Sumitomo Dainippon Pharma Co Ltd Company Overview
      • Sumitomo Dainippon Pharma Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sumitomo Dainippon Pharma Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table LONASEN Patch - Product Status
        • Table LONASEN Patch - Product Description
    • Sun Pharma Advanced Research Company Ltd Company Overview
      • Sun Pharma Advanced Research Company Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sun Pharma Advanced Research Company Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biodegradable Implant - Product Status
        • Table Biodegradable Implant - Product Description
    • Syntropharma Ltd Company Overview
      • Syntropharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Syntropharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table MAOI Transdermal Patch - Product Status
        • Table MAOI Transdermal Patch - Product Description
    • Taho Pharmaceuticals Ltd Company Overview
      • Taho Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Taho Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table TAH8801 Patch - Product Status
        • Table TAH8801 Patch - Product Description
        • Table TAH9901 Patch - Product Status
        • Table TAH9901 Patch - Product Description
    • Teikoku Pharma USA Inc Company Overview
      • Teikoku Pharma USA Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Teikoku Pharma USA Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TPU-002 - Product Status
        • Table TPU-002 - Product Description
        • Table TPU-006 - Product Status
        • Table TPU-006 - Product Description
        • Table TPU-010 - Product Status
        • Table TPU-010 - Product Description
    • Teikoku Seiyaku Co Ltd Company Overview
      • Teikoku Seiyaku Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Teikoku Seiyaku Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transdermal Hydrogel Patch - Back Pain - Product Status
        • Table Transdermal Hydrogel Patch - Back Pain - Product Description
    • tesa Labtec GmbH Company Overview
      • tesa Labtec GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table tesa Labtec GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table LabiPatch - Cold Sores - Product Status
        • Table LabiPatch - Cold Sores - Product Description
    • Teva Pharmaceutical Industries Ltd Company Overview
      • Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Teva Pharmaceutical Industries Ltd Drug Delivery Patch - Product Status
        • Table Teva Pharmaceutical Industries Ltd Drug Delivery Patch - Product Description
    • The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview
      • The Sheikh Zayed Institute for Pediatric Surgical Innovation Pipeline Products & Ongoing Clinical Trials Overview
        • Table The Sheikh Zayed Institute for Pediatric Surgical Innovation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanoliposomal Transdermal Drug Delivery System - Product Status
        • Table Nanoliposomal Transdermal Drug Delivery System - Product Description
    • TheraJect Inc Company Overview
      • TheraJect Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TheraJect Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table DrugMAT - Product Status
        • Table DrugMAT - Product Description
        • Table VaxMAT - Product Status
        • Table VaxMAT - Product Description
    • TheraSolve NV Company Overview
      • TheraSolve NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table TheraSolve NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table MemoPatch - Product Status
        • Table MemoPatch - Product Description
    • Theratech, Inc. Company Overview
      • Theratech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Theratech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table ChemoPatch - Product Status
        • Table ChemoPatch - Product Description
    • Titan Pharmaceuticals Inc Company Overview
      • Titan Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Titan Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Probuphine Subdermal Implant - Product Status
        • Table Probuphine Subdermal Implant - Product Description
        • Table ProNeura Antimalarial Implant - Product Status
        • Table ProNeura Antimalarial Implant - Product Description
        • Table Ropinirole Implant - Product Status
        • Table Ropinirole Implant - Product Description
        • Table T3 Implant - Hypothyroidism - Product Status
        • Table T3 Implant - Hypothyroidism - Product Description
        • Table Titan Pharmaceuticals Inc - Ongoing Clinical Trials Overview
        • Table Ropinirole Implant - An Open-label, Relative Bioavailability Study Evaluating the Safety, Tolerability and Pharmacokinetics of Ropinirole Implants in Patients with Parkinson's Disease Switched From Oral Immediate-Release Ropinirole While on L-Dopa
        • Table Ropinirole Implant - Proof of Concept Study of ProNeura-ropinirole
    • Transcu Group Limited (Inactive) Company Overview
      • Transcu Group Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transcu Group Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transdermal Drug Delivery System - Product Status
        • Table Transdermal Drug Delivery System - Product Description
    • Transdermal Delivery Solutions Corp Company Overview
      • Transdermal Delivery Solutions Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transdermal Delivery Solutions Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table HypoSpray - Product Status
        • Table HypoSpray - Product Description
        • Table Transdermal Delivery Solutions Corp - Ongoing Clinical Trials Overview
        • Table HypoSpray - A Multiple-dose, Single Period, Phase II Dose Ranging Study to Examine Testagen TDS-Testosterone 5% in Adult Male Subjects
        • Table HypoSpray - A Single-dose, Single Period, Phase II Pharmacokinetic Study to Examine Testagen TDS-testosterone for Its Potential to be Inadvertently Transferred by Skin Contact after Dosing in Healthy Adult Subjects
    • TransPharma Medical Ltd (Inactive) Company Overview
      • TransPharma Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table TransPharma Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table ViaDerm-hGH - Product Status
        • Table ViaDerm-hGH - Product Description
        • Table ViaDor - hPTH - Product Status
        • Table ViaDor - hPTH - Product Description
    • Transport Pharmaceuticals Inc Company Overview
      • Transport Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transport Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SoloVir Electrokinetic Transdermal System - Product Status
        • Table SoloVir Electrokinetic Transdermal System - Product Description
    • TSRL Inc Company Overview
      • TSRL Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TSRL Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microneedle Patch - Product Status
        • Table Microneedle Patch - Product Description
    • Univec, Inc. (Inactive) Company Overview
      • Univec, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Univec, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nicotine Replacement Patch - Product Status
        • Table Nicotine Replacement Patch - Product Description
        • Table Univec, Inc. (Inactive) - Ongoing Clinical Trials Overview
        • Table Nicotine Replacement Patch - Nicotine Dependence, Withdrawal and Replacement Therapy Assessed by PET Imaging
    • University of Illinois at Chicago Company Overview
      • University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transdermal Drug Delivery Device - Breast Cancer - Product Status
        • Table Transdermal Drug Delivery Device - Breast Cancer - Product Description
    • University of Toronto Company Overview
      • University of Toronto Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Toronto Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microneedle Transdermal Patch - Hypoglycemia - Product Status
        • Table Microneedle Transdermal Patch - Hypoglycemia - Product Description
    • Vyteris, Inc. (Inactive) Company Overview
      • Vyteris, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vyteris, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Smart Patch Iontophoretic Drug Delivery - Product Status
        • Table Smart Patch Iontophoretic Drug Delivery - Product Description
    • Yale University Company Overview
      • Yale University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Yale University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biodegradable Contraceptive Implant - Product Status
        • Table Biodegradable Contraceptive Implant - Product Description
    • Zambon Italia Srl Company Overview
      • Zambon Italia Srl Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zambon Italia Srl Pipeline Products & Ongoing Clinical Trials Overview
        • Table ZP-024 - Product Status
        • Table ZP-024 - Product Description
    • Z-Cube Srl Company Overview
      • Z-Cube Srl Pipeline Products & Ongoing Clinical Trials Overview
        • Table Z-Cube Srl Pipeline Products & Ongoing Clinical Trials Overview
        • Table Embedded Carbon Nanotube Skin Patch - Product Status
        • Table Embedded Carbon Nanotube Skin Patch - Product Description
    • Zosano Pharma Corp Company Overview
      • Zosano Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zosano Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table M207 Patch - Product Status
        • Table M207 Patch - Product Description
        • Table Teribone - Product Status
        • Table Teribone - Product Description
    • Zynerba Pharmaceuticals Inc Company Overview
      • Zynerba Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zynerba Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ZYN001 - THC Pro-Drug Patch - Product Status
        • Table ZYN001 - THC Pro-Drug Patch - Product Description
        • Table Zynerba Pharmaceuticals Inc - Ongoing Clinical Trials Overview
        • Table ZYN001 - THC Pro-Drug Patch - Phase I Bio-equivalence Study of ZYN-001 in Healthy Volunteers
        • Table ZYN001 - THC Pro-Drug Patch - Phase I Multiple Rising Study of ZYN-001
        • Table ZYN001 - THC Pro-Drug Patch - Phase I Single and Multiple Rising Dose Study of ZYN-001 in Healthy Subjects
        • Table ZYN001 - THC Pro-Drug Patch - Phase IIa Study of ZYN-001 in Subjects with Fibromyalgia
        • Table ZYN001 - THC Pro-Drug Patch - Phase IIa Study of ZYN-001 in Subjects with Peripheral
  • Transdermal Drug Delivery Devices - Recent Developments
    • Sep 20, 2017: DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
    • Sep 19, 2017: FluGen Announces Expanded Role for Clinical Advisory Board: Dr. Robert Belshe to Chair
    • Sep 18, 2017: National Institute on Drug Abuse Awards Pain Therapeutics $2.2 Million Grant
    • Sep 14, 2017: Intarcia and Numab Reach Key Milestone with Selection of Multi-specific Development Candidate for Autoimmune Disease
    • Sep 12, 2017: FDA Acknowledges Receipt Of Sorrento Therapeutics NDA For ZTlido; PDUFA Date Set For February 28, 2018
    • Sep 11, 2017: Teva Names Kare Schultz as President and Chief Executive Officer
    • Sep 11, 2017: The Allergan Foundation to Donate $150,000 to Support Hurricane Irma Relief Efforts
    • Sep 07, 2017: Aequus Announces Positive Results for Proof of Concept Clinical Trial of Anti-Nausea Patch
    • Sep 07, 2017: Agile Therapeutics to Present Additional Phase 3 Data at the 73rd Annual Congress of the American Society for Reproductive Medicine
    • Sep 07, 2017: Lilly Takes Steps To Streamline Business, Invest In New Medicines And Drive Growth
    • Sep 06, 2017: Revance Appoints Mark Foley to its Board of Directors
    • Sep 05, 2017: FluGen Announces C. Boyd Clarke Has Been Named Executive Chairman
    • Sep 01, 2017: Start of MRX-4TZT Phase I a' Clinical Trial in the United States
    • Aug 31, 2017: Kyowa Hakko Kirin: Announcement of submission of supplemental new drug application for the addition of a new 0.5mg dose of the transdermal, long-acting pain relief patch FENTOS TAPE
    • Aug 31, 2017: Aquavit's iMicrotox (IMX-001) Study Receives IRB Approval
    • Aug 30, 2017: GSK responds to UK Life Sciences Industrial Strategy
    • Aug 29, 2017: Sorrento Therapeutics Submits NDA For ZTlidoNext-Generation Lidocaine Patch
    • Aug 29, 2017: Aequus Provides Second Quarter 2017 Operational Highlights
    • Aug 24, 2017: Titan Pharmaceuticals Receives FDA Clearance To Begin Clinical Study Of Parkinson's Disease Treatment
    • Aug 24, 2017: Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole
    • Aug 23, 2017: Lannett Reports Fiscal 2017 Fourth-Quarter And Full-Year Financial Results, Provides Guidance For Fiscal 2018
    • Aug 22, 2017: Medtronic Reports First Quarter Financial Results
    • Aug 11, 2017: SteadyMed Reports Second Quarter 2017 Financial Results and Provides Corporate Update
    • Aug 11, 2017: Valeritas Reports Second Quarter 2017 Financial Results
    • Aug 10, 2017: Zosano Pharma Reports Second Quarter 2017 Financial Results and Operational Update
    • Aug 10, 2017: Alliqua BioMedical Reports Second Quarter of Fiscal Year 2017 Financial Results
    • Aug 09, 2017: The Medicines Company Reports Second Quarter 2017 Business and Financial Results
    • Aug 08, 2017: DURECT Announces Second Quarter 2017 Financial Results and Provides Corporate Update
    • Aug 08, 2017: Lannett Announces Preliminary Fiscal 2017 Fourth-Quarter And Full-Year Financial Results, Comments On Fiscal 2018 Outlook
    • Aug 08, 2017: Antares Pharma Reports Second Quarter 2017 Operating And Financial Results
    • Aug 07, 2017: EyeGate Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update
    • Aug 03, 2017: Teva Reports Second Quarter 2017 Financial Results
    • Aug 03, 2017: Allergan Reports Continued Strong Execution in Second Quarter 2017 with 9% Increase in GAAP Net Revenues to $4.0 Billion
    • Aug 03, 2017: Revance Releases Second Quarter 2017 Results
    • Aug 03, 2017: Corium Reports Recent Corporate Highlights and Financial Results for Third Quarter Fiscal 2017
    • Aug 01, 2017: EyeGate Pharma Enrolls First Patient in Phase 2b Clinical Study of EGP- 437 for Cataract Surgery
    • Jul 31, 2017: Perrigo Announces Launch Of AB Rated Generic Version Of Transderm Scop 1.5 mg
    • Jul 31, 2017: SteadyMed Appoints Jeff Myers M.D. Ph.D. Vice President of Medical Affairs
    • Jul 28, 2017: Agile Therapeutics Reports Second Quarter 2017 Financial Results
    • Jul 27, 2017: Agile Therapeutics Announces FDA Acceptance Of The NDA Resubmission Of Twirla
    • Jul 27, 2017: UCB with a strong first half year 2017 – giving rise to the financial outlook for 2017
    • Jul 26, 2017: GSK delivers further progress in Q2 and sets out new priorities for the Group
    • Jul 25, 2017: Karenann Terrell appointed Chief Digital & Technology Officer, GSK
    • Jul 25, 2017: Lilly Reports Second-Quarter Results
    • Jul 25, 2017: 3M Delivers Second-Quarter Sales of $7.8 Billion and Earnings of $2.58 per Share; Company Updates Its 2017 Outlook
    • Jul 23, 2017: Teva to Terminate Around 300 jobs in Israel
    • Jul 21, 2017: GSK announces Board and Committee changes
    • Jul 19, 2017: Joseph H. Boccuzi Appointed to Allergan Board of Directors
    • Jul 18, 2017: Corium Presents Clinical Results from Pilot Bioequivalence Study of Corplex Donepezil Transdermal System at Alzheimer's Association International Conference 2017
    • Jul 17, 2017: Lannett Appoints Samuel H. Israel As General Counsel
    • Jul 13, 2017: Camurus: Interim report January-June 2017
    • Jul 13, 2017: Teva Enhances Board of Directors as All Proposals Approved at Annual General Meeting of Shareholders
    • Jul 06, 2017: Corium to Present Clinical Results from Pilot Bioequivalence Study of Once-weekly Corplex Donepezil Transdermal System at Alzheimer's Association International Conference 2017
    • Jul 05, 2017: Aequus Receives Approval from Health Canada to Initiate Proof of Concept Clinical Trial of Anti-Nausea Patch
    • Jul 04, 2017: Sumitomo Dainippon Pharma Announces Change in Name of Consolidated Subsidiary Based in U.S.
    • Jun 29, 2017: Fortune Article Highlights Titan Pharmaceuticals And Its ProNeura Technology
    • Jun 27, 2017: Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Contraceptive Patch, Twirla
    • Jun 26, 2017: Zynerba Pharmaceuticals Initiates ZYN001 Phase 1 Clinical Program
    • Jun 26, 2017: Medherant expands management team with appointment of Sally Waterman, COO and Angus Hone, CFO
    • Jun 22, 2017: Dr. Craig Landau Appointed President and CEO Purdue Pharma L.P.
    • Jun 21, 2017: Eli Lilly And Company Unveils Expanded Biotechnology Center In San Diego
    • Jun 20, 2017: Lannett Names Patrick G. LePore To Board of Directors
    • Jun 19, 2017: GSK confirms start date for Luke Miels
    • Jun 16, 2017: Sumitomo Dainippon Pharma announces personnel change
    • Jun 15, 2017: Aequus Advances Clinical Development of Transdermal Anti-Nausea Patch
    • Jun 14, 2017: Sorrento Therapeutics' Pain Subsidiary, SCILEX Pharmaceuticals, Announces Positive Data from Head to Head Adhesion Study with its Lead Product, ZTlido
    • Jun 14, 2017: Zosano Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    • Jun 13, 2017: Braeburn and Knight Therapeutics Announce Filing of PROBUPHINE in Canada
    • Jun 06, 2017: Medherant Appoints Sheryl Caswell to Lead Clinical Development of Products Based on its Revolutionary TEPI Patch
    • Jun 06, 2017: Valeritas Appoints Peter J. Devlin to Chairman of its Board of Directors
    • Jun 01, 2017: Derica Rice To Retire As Lilly Chief Financial Officer
    • Jun 01, 2017: Aequus Pharmaceuticals and CDRD Announce Research Collaboration to Improve Cannabinoid-Based Therapeutics
    • Jun 01, 2017: Tapemark Manufacturing Facility Completes Successful FDA Pre-Approval and General GMP Inspection
    • May 30, 2017: Patent Granted in Japan for a Transdermal Drug with Acid Scavenger
    • May 30, 2017: Aequus Provides First Quarter 2017 Financial Highlights
    • May 29, 2017: Phosphagenic - Mylan Arbitration Update – expert report on quantum of damages claimed filed
    • May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
    • May 18, 2017: Nemaura Pharma Memspatch Addresses Diabetics Fear of Needle Puncture Pain
    • May 15, 2017: Radius Health Appoints Pharmaceutical Executive Jose Carmona as Chief Financial Officer
    • May 12, 2017: SteadyMed Reports First Quarter 2017 Financial Results and Provides Corporate Update
    • May 12, 2017: Valeritas Reports First Quarter 2017 Financial Results
    • May 11, 2017: Corium Reports Positive Preliminary Results in Alzheimer's Clinical Study
    • May 11, 2017: Teva Reports First Quarter 2017 Financial Results
    • May 11, 2017: Corium Reports Second Quarter Fiscal 2017 Financial Results and Recent Corporate Highlights
    • May 10, 2017: Leigh Ann Pusey Joins Lilly as Senior Vice President of Corporate Affairs and Communications
    • May 10, 2017: DURECT Announces First Quarter 2017 Financial Results and Provides Corporate Update
    • May 10, 2017: Nuvo Pharmaceuticals Announces 2017 First Quarter Results
    • May 09, 2017: Allergan Reports Solid Start to 2017 with 5% Increase in First Quarter GAAP Net Revenues to $3.6 Billion
    • May 09, 2017: Revance Releases First Quarter 2017 Results
    • May 09, 2017: Alliqua BioMedical Reports First Quarter of Fiscal Year 2017 Financial Results
    • May 09, 2017: Zosano Reports First Quarter 2017 Financial Results and Announces Management Changes
    • May 09, 2017: Antares Pharma Reports First Quarter 2017 Operating and Financial Results
    • May 08, 2017: Medherant Appoints Laboratoires Plasto Santé as Transdermal Drug Delivery Patch Manufacturer
    • May 08, 2017: EyeGate Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Update
    • May 08, 2017: Agile Therapeutics Reports First Quarter 2017 Financial Results
    • May 08, 2017: Sumitomo Dainippon Pharma announces personnel change
    • May 06, 2017: Agile Therapeutics Reports Additional Phase 3 SECURE Study Results Relating to Twirla at ACOG 2017
    • May 04, 2017: Apricus Biosciences Announces the Initiation of Vitaros Drug-Device Human Factors Study
    • May 03, 2017: Camurus Announces Interim Report January-March 2017
    • May 02, 2017: Lannett Reports Fiscal 2017 Third-Quarter Financial Results
    • May 01, 2017: Radius Health Reports First Quarter 2017 Financial and Operating Results
    • May 01, 2017: Aequus Provides Fourth Quarter and Fiscal 2016 Financial Highlights
    • Apr 27, 2017: Agile Therapeutics Announces Presentation of SECURE Phase 3 Data at the 2017 Congress on Women's Health
    • Apr 26, 2017: Axiron Net Sales, quarter to March 2017
    • Apr 26, 2017: Teva Announces Planned Departure of Eyal Desheh, Group Executive Vice President and Chief Financial Officer
    • Apr 26, 2017: The Medicines Company Reports First-Quarter 2017 Financial Results
    • Apr 26, 2017: GSK delivers another quarter of continued progress
    • Apr 25, 2017: Lilly Reports First-Quarter 2017 Results
    • Apr 25, 2017: 3M Delivers First-Quarter Sales of $7.7 Billion and Earnings of $2.16 per Share; Company Raises Its Full-Year 2017 Outlook
    • Apr 24, 2017: UCB First Three Months Interim Report 2017: UCB with a good start into 2017
    • Apr 24, 2017: Purdue Pharma Names Josie Martin Head of Corporate Affairs & Communications
    • Apr 21, 2017: Phosphagenics Announces Transition of Chairman of the Board
    • Apr 21, 2017: Purdue Pharma Announces Hire of Carrie Chomiak to Lead Over-the- Counter Franchise
    • Apr 19, 2017: FDA Meeting Confirms Development Policy for MRX-1OXT
    • Apr 10, 2017: Allergan Receives 2017 ENERGY STAR Partner of the Year – Sustained Excellence Award from U.S. Environmental Protection Agency
    • Apr 06, 2017: Alliqua BioMedical Announces Preliminary First Quarter Fiscal 2017 Revenue and Updates Fiscal Year 2017 Outlook
    • Apr 06, 2017: Allergan Names Daphne Karydas as Senior Vice President of Global Investor Relations & Strategy
    • Apr 04, 2017: Lilly and Ohio University Heritage College of Osteopathic Medicine Partner on Rotation Program for Medical Students
    • Apr 03, 2017: Aequus Announces Positive Results from Second Proof of Concept Study for Long-Acting Aripiprazole Transdermal Patch
    • Mar 31, 2017: The Medicines Company Appoints Paris Panayiotopoulos to Its Board of Directors
    • Mar 31, 2017: Camurus appoints VP Corporate Development & General Counsel
    • Mar 30, 2017: Lannett Voluntarily Pays Down Additional $25 Million Of Revolving Credit Facility
    • Mar 29, 2017: Sumitomo Dainippon Pharma announces Changes in Executive Officers
    • Mar 24, 2017: UCB General Meeting on 27 April 2017
    • Mar 22, 2017: Sumitomo Dainippon Pharma Announces New Chief Executive Officer at Boston Biomedical and Establishment of Global Head of Oncology
    • Mar 21, 2017: Recipharm partners with Sato to manufacture product for Japanese market
    • Mar 20, 2017: Corium Reports Positive Progress in Pilot Bioequivalence Study of Once- Weekly Corplex Donepezil Patch
    • Mar 16, 2017: KalVista Pharmaceuticals Reports Fiscal Third Quarter Results
    • Mar 14, 2017: DURECT Announces Fourth Quarter and Full Year 2016 Financial Results and Update of Programs
    • Mar 14, 2017: Antares Pharma Reports Fourth Quarter and Full Year 2016 Operating and Financial Results
    • Mar 09, 2017: KalVista Pharmaceuticals Appoints Dr. Andreas Maetzel Senior Vice President of Medical
    • Mar 08, 2017: Agile Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
    • Mar 07, 2017: Alliqua BioMedical Reports Fourth Quarter and Fiscal Year 2016 Financial Results
    • Mar 05, 2017: Data at AAAAI 2017 Show Lasting Response and Favorable Safety Profile of Investigational Agent, Viaskin Peanut, Throughout Three Years of Treatment of Peanut Allergic Children
    • Mar 02, 2017: Lilly Announces Changes In Senior Management
    • Mar 01, 2017: Zosano Pharma Reports Fourth Quarter and Fiscal 2016 Financial Results and Business Update
    • Mar 01, 2017: Nuvo Pharmaceuticals Announces 2016 Year-End and Fourth Quarter Results
    • Feb 28, 2017: Phosphagenics Full Year Financial Results
    • Feb 28, 2017: The Medicines Company Reports Fourth-Quarter and Full-Year 2016 Financial Results
    • Feb 27, 2017: Titan Pharmaceuticals Receives FDA Communication On Ropinirole Implant Investigational New Drug Application
    • Feb 27, 2017: Lisa DeFrancesco, Vice President of Investor Relations, to Leave Allergan
    • Feb 27, 2017: Revance Releases Fourth Quarter and Full Year 2016 Results
    • Feb 24, 2017: Sumitomo Dainippon Pharma announces Changes of Representative Directors and Executive Officers
    • Feb 23, 2017: Lannett Announces Addition To Management Team
    • Feb 23, 2017: Radius Health Reports Fourth Quarter and Full Year 2016 Financial and Operating Results
    • Feb 23, 2017: EyeGate Pharmaceuticals Reports Full-year 2016 Financial Results and Provides Business Update
    • Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
    • Feb 21, 2017: Valeritas Reports Fourth Quarter and Full Year 2016 Financial Results
    • Feb 17, 2017: TSRL Awarded NIH Grant to Develop Microneedle Patch for Treatment of Influenza
    • Feb 16, 2017: Camurus Announces Full year report 2016
    • Feb 16, 2017: GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms
    • Feb 14, 2017: Aequus Successfully Completes Dosing in Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch
    • Feb 13, 2017: Teva Reports Full Year and Fourth Quarter 2016 Financial Results
    • Feb 13, 2017: Corium Reports First Quarter Fiscal 2017 Financial Results
    • Feb 09, 2017: Carolyn R. Bertozzi, Ph.D., Elected To Lilly Board Of Directors
    • Feb 08, 2017: Allergan Reports Strong 2016 Finish with 7% Increase in GAAP Net Revenues to $3.9 Billion in Fourth Quarter 2016
    • Feb 08, 2017: GlaxoSmithKline: Results announcement for the fourth quarter 2016
    • Feb 07, 2017: Medherant Announces Appointment of New Chair
    • Feb 07, 2017: Cynosure Achieves Record Quarterly Revenue of $122.1 Million in the Fourth Quarter of 2016, Up 19 Percent Year-over-Year
    • Feb 07, 2017: Haselmeier Appoints Paul Jansen as Senior Advisor and Member of the Board of Directors
    • Feb 06, 2017: Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman
    • Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
    • Feb 06, 2017: EyeGate Pharmaceuticals Announces Executive Promotions
    • Feb 06, 2017: Noven Appoints Mark Jackson as Vice President – Quality
    • Feb 06, 2017: Medherant appoints new chair
    • Feb 03, 2017: Phase I Clinical Trial Results for MRX-4TZT in the United States
    • Feb 01, 2017: Lannett Reports Fiscal 2017 Second-Quarter Financial Results
    • Jan 31, 2017: Lilly Reports Fourth-Quarter And Full-Year 2016 Results
    • Jan 25, 2017: Yutaka Niihara, MD, MPH, CEO of Emmaus Appointed Executive Chairman of Generex Biotechnology
    • Jan 23, 2017: EyeGate Pharma Awarded Canadian Patent for Proprietary Iontophoretic Formulation and Use of the Formulation for Ocular Delivery of Dexamethasone Phosphate
    • Jan 20, 2017: Change of Registered Office and Principal Place of Business
    • Jan 20, 2017: Luke Miels will succeed Abbas Hussain as President, Global Pharmaceuticals, GSK
    • Jan 19, 2017: Abbas Hussain to leave GSK
    • Jan 19, 2017: Luke Miels appointed President, Global Pharmaceuticals, GSK
    • Jan 13, 2017: Braeburn Pharmaceuticals' Probuphine Implant Receives J-Code by Centers for Medicare & Medicaid Services
    • Jan 09, 2017: Sorrento Subsidiary, SCILEX Pharmaceuticals, Announces Key Endpoints Met in the European Union Pivotal Bioequivalence Clinical Study for Its Lead Product, ZTlido
    • Jan 09, 2017: Aequus Initiates Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch
    • Jan 06, 2017: Teva Provides 2017 Financial Outlook
    • Jan 05, 2017: Lilly To Adjust Organization And Leadership Structure To Better Align With Growth Opportunities
    • Jan 05, 2017: Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference and Provides Preliminary Comments on 2017 Outlook
    • Jan 03, 2017: Agile Therapeutics Announces Positive Top-line Phase 3 Results
    • Jan 03, 2017: Apricus Biosciences Promotes Mary Naggs to Vice President, General Counsel
    • Dec 27, 2016: Apricus Biosciences Announces the Launch of Vitaros for the Treatment of Erectile Dysfunction in Lebanon by Elis Pharmaceuticals
    • Dec 22, 2016: Teva Reaches Settlement with Government on FCPA
    • Dec 22, 2016: Teva Pharmaceutical Paying $519 Million to Settle FCPA Charges
    • Dec 19, 2016: GSK announces Board changes
    • Dec 15, 2016: Lilly Provides 2017 Financial Guidance And 2016 Update, Reaffirms Financial Expectations Through The Remainder Of The Decade
    • Dec 15, 2016: New appointments on UCB's Board of Directors
    • Dec 13, 2016: TUV Certification for the Bengaluru Facility
    • Dec 12, 2016: Reformulation of Phosphagenics' Transdermal TPM/Oxymorphone Patch Complete
    • Dec 12, 2016: Skin patch with Microneedles Proves Effective Alternative to Injections
    • Dec 12, 2016: Echo Therapeutics Announces Federal Court's Denial Of Preliminary Injunction And Lifting Of Temporary Restraining Order
    • Dec 08, 2016: Acrux Announces Director Resignation
    • Dec 07, 2016: SteadyMed appoints vice president of PH patient advocacy and community relations
    • Dec 05, 2016: SCILEX Pharmaceuticals Announces Key Endpoints Met in Pivotal Bioequivalence Clinical Study for Its Lead Product, ZTlido
    • Dec 05, 2016: Teva Appoints Dipankar Bhattacharjee as President and Chief Executive Officer, Global Generic Medicines Group, Succeeding Siggi Olafsson
    • Nov 30, 2016: Valeritas Elects Joe Mandato, Ph.D., Experienced Medical Device Executive and Investor, to Board of Directors
    • Nov 30, 2016: Aequus Provides Q3 2016 Financial Highlights With Substantial Increase in Quarter Over Quarter Revenues
    • Nov 22, 2016: Notice of Termination of Development of ETOREAT
    • Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
    • Nov 22, 2016: Innocoll Announces Third Quarter 2016 Financial and Operating Results and Provides Corporate Update
    • Nov 21, 2016: Corium Reports Fourth Quarter and Fiscal Year 2016 Financial Results and Recent Corporate Highlights
    • Nov 18, 2016: Apricus Biosciences Provides Update on Vitaros NDA Following Receipt of FDA Feedback
    • Nov 17, 2016: Aequus Prepares for Proof of Concept Clinical Study for Transdermal Anti-Nausea Diclegis Program
    • Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
    • Nov 16, 2016: Nuvo Pharmaceuticals appoints new president
    • Nov 16, 2016: Nuvo Pharmaceuticals Appoints Jesse Ledger as President
    • Nov 15, 2016: Teva Reports Third Quarter 2016 Results
    • Nov 15, 2016: Cynosure Health Welcomes Three New Board Members
    • Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction
    • Nov 14, 2016: Adriane M. Brown to Join Allergan Board of Directors
    • Nov 11, 2016: Sumitomo Dainippon Pharma Announces Organizational Realignment and Changes Related to Officers and Other Key Positions
    • Nov 10, 2016: Phosphagenics Extends Due Diligence Period for Opioid Patches in Japan
    • Nov 10, 2016: Nuvo Pharmaceuticals Announces 2016 Third Quarter Results
    • Nov 10, 2016: Valeritas Reports Third Quarter 2016 Financial Results
    • Nov 09, 2016: Antares Pharma Reports Third Quarter 2016 Financial and Operating Results
    • Nov 09, 2016: Zosano Pharma Reports Third Quarter 2016 Financial Results
    • Nov 08, 2016: Teva Announces Appointment of New Chief Legal Officer
    • Nov 07, 2016: Agile Therapeutics Reports Third Quarter 2016 Financial Results
    • Nov 07, 2016: Camurus: Interim report January-September 2016
    • Nov 04, 2016: Alliqua BioMedical Reports Third Quarter and Nine-Months Fiscal Year 2016 Financial Results
    • Nov 03, 2016: Lannett Reports Fiscal 2017 First-Quarter Financial Results
    • Nov 03, 2016: Revance Releases Third Quarter 2016 Results
    • Nov 03, 2016: Radius Health Reports Third Quarter 2016 Financial and Operating Results
    • Nov 02, 2016: Allergan Reports Third Quarter 2016 Continuing Operations Performance with GAAP Net Revenues of $3.6 Billion; Announces Accelerated Share Repurchase, Initiation of Cash Dividend
    • Nov 02, 2016: EyeGate Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update
    • Nov 01, 2016: Cynosure Promotes Doug Delaney to Chief Commercial Officer
    • Oct 31, 2016: DURECT Announces Third Quarter 2016 Financial Results and Update of Programs
    • Oct 31, 2016: Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer
    • Oct 28, 2016: Probuphine Implant for Opioid Dependence Featured at 2016 International Society of Addiction Medicine Meeting
    • Oct 27, 2016: Probuphine Wins Popular Science's "Best of What's New" Award
    • Oct 26, 2016: Apricus Biosciences Announces Approval of Vitaros for the Treatment of Erectile Dysfunction in Greece
    • Oct 26, 2016: Allergan Announces Changes to Board Leadership
    • Oct 26, 2016: GlaxoSmithKline: Results Announcement for the third quarter 2016
    • Oct 26, 2016: The Medicines Company Reports Third-Quarter 2016 Financial Results
    • Oct 25, 2016: Cynosure Announces Record Third-Quarter Revenues; Revenues Increase 36 Percent from Prior Year to $106.4 Million
    • Oct 25, 2016: Lilly Reports Third-Quarter 2016 Results
    • Oct 20, 2016: JDRF and the University of Toronto support research into a skin patch to prevent common, life-threatening risk of T1D
    • Oct 17, 2016: Aequus Advances Clinical Development of Transdermal Aripiprazole Patch
    • Oct 17, 2016: Hisamitsu America, the Global Leader of Topical Pain Patches, Introduces the Salonpas Lidocaine 4% Pain Relieving Gel-Patch
    • Oct 17, 2016: Zynerba Provides Clinical Update for Lead Development Candidate ZYN001
    • Oct 17, 2016: Braeburn Pharmaceuticals to Conduct Series of Probuphine (buprenorphine) Implant Trainings in Salt Lake City on October 27-29, 2016 for Qualified Healthcare Providers
    • Oct 07, 2016: Start of MRX-4TZT Phase I Clinical Trial in the United States
    • Oct 06, 2016: MEDRx: Presentation to Vaccinology Society about Immunogenicity for Transdermal Vaccines Using Microneedles
    • Oct 05, 2016: Alliqua BioMedical Announces Preliminary Third Quarter of Fiscal Year 2016 Revenue
    • Oct 05, 2016: New Study Showcases Economic Impact of Allergan's Operations on New Jersey Economy
    • Oct 05, 2016: Alliqua BioMedical Announces Preliminary Third Quarter of Fiscal Year 2016 Revenue; Earnings Conference Call Scheduled for November 4th
    • Oct 03, 2016: Noven Appoints Ralph Lipp, PH.D., as Vice President and Chief Scientific Officer
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report